arrow_back Trending Legislation
Share share

Global Pandemic Preparedness: Accelerating Medical Product Development and Access.

This act aims to establish a global strategy to accelerate the development and availability of medicines and vaccines for future pandemics. Through international cooperation, citizens can expect faster access to essential medical products in public health emergencies, enhancing their safety and protection.
Key points
International Cooperation: The U.S. government will seek support from other countries and organizations to jointly develop medical products against pandemics.
Faster Access to Medicines: The goal is to accelerate research, production, and market entry of medicines and vaccines, including those for superbugs.
Efficient Resource Use: The strategy aims to ensure that funds and efforts are used efficiently, avoiding duplication and focusing on the most critical health threats.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
SUPER BUGS Act of 2023
Print number: HR 1305
Sponsor: Rep. Levin, Mike [D-CA-49]
Process start date: 2023-03-01
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Global Pandemic Preparedness: Accelerating Medical Product Development and Access.

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 1305.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-03-01.

What are the main provisions?

Key points include:

  • International Cooperation: The U.S. government will seek support from other countries and organizations to jointly develop medical products against pandemics.
  • Faster Access to Medicines: The goal is to accelerate research, production, and market entry of medicines and vaccines, including those for superbugs.
  • Efficient Resource Use: The strategy aims to ensure that funds and efforts are used efficiently, avoiding duplication and focusing on the most critical health threats.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Levin, Mike [D-CA-49].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Foreign Affairs.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

Analysis and Potential Impact of HR 1305

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health